HOOK - HOOKIPA Pharma to participate in upcoming investor conferences in September | Benzinga
NEW YORK and VIENNA, Austria, Sept. 06, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ:HOOK, ‘HOOKIPA')), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that HOOKIPA's management team will participate in and present at the following upcoming investor conferences:
Morgan Stanley Global Healthcare Conference, September 11-13, New York
Fireside Chat: Monday, September 11, 3:35pm ET
H.C. Wainwright Global Investment Conference, September 11-13, New York
Fireside Chat: Tuesday, September 12, 11:30am ET
In addition to the presentations, HOOKIPA will also host one-on-one investor meetings.
About HOOKIPA
HOOKIPA Pharma Inc. (NASDAQ:HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which are designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. HOOKIPA's replicating and non-replicating technologies are engineered to induce robust and durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. HOOKIPA's pipeline includes its wholly owned investigational arenaviral immunotherapies targeting Human Papillomavirus 16-positive cancers, prostate cancers, and other undisclosed programs. HOOKIPA is collaborating with Roche on an arenaviral ...